Patents for A61P 17 - Drugs for dermatological disorders (106,455)
01/2008
01/30/2008CN101112436A Chinese medicine preparation for treating bacchia
01/30/2008CN101112435A Chinese traditional medicine for treating children's eczema
01/30/2008CN101112434A Leukoderma treating medicine
01/30/2008CN101112427A Externally-used Chinese traditional medicine ointment for treating paronychia
01/30/2008CN101112420A Chinese patent drug for treating and nursing scar
01/30/2008CN101112418A Medicinal composition for part use for treating acne and method for preparing the same
01/30/2008CN101112404A Chinese traditional medicine for treating condyloma acuminata
01/30/2008CN101112389A Externally used antifungal drug for treating skin fester infection
01/30/2008CN101112388A Method for treating empyrosis, sunburn, decubitus, ulcer, frostbite and wound
01/30/2008CN101112382A Povidone iodine wiping sheet
01/30/2008CN101112366A Skin-protecting wiping slice
01/30/2008CN101112365A Method for preparing Nabothí»s cyst containing manifold cell growth factors and use thereof
01/30/2008CN101112355A Method for preparing extract of active ingredient in hairy bamboo
01/30/2008CN101112354A Method for preparing extract of active ingredient in hairy bamboo
01/30/2008CN101112347A Anti- mosquito wiping sheet
01/30/2008CN101112237A Health products having a function of dispelling chloasma
01/30/2008CN100365020C Protein from snake venom for preventing and treating pyemia
01/30/2008CN100364991C Crystals including a malic acid salt of a 3-pyrrole substituted 2-indolinone, and compositions thereof
01/30/2008CN100364939C Chinese medicine effective-part extract for treating hypersensitive diseases and extraction process
01/30/2008CN100364588C Externally applied medicine for treating white hair and its preparation method
01/30/2008CN100364581C Externally applied agent for burn and preparing method
01/30/2008CN100364568C Heat clearing and detoxicating pill containing vomiting nut
01/30/2008CN100364550C Externally applied powder for astringing sore, removing necrotic tissue and regenerating tissue
01/30/2008CN100364543C External preparation for inhibiting keloid formation
01/30/2008CN100364527C Composition of vitamin C and arginine and its application
01/30/2008CN100364510C Drop pills of oldenlandia and preparing method
01/29/2008US7323491 Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
01/29/2008US7323474 Pyridine derivatives inhibiting angiogenesis and/or VEGF receptor tyrosine kinase
01/29/2008US7323472 Antiarthritic agents; sepsis shock; malaria; antiischemic agents; respiratory system disorders; brain disorders; congestive heart failure
01/29/2008US7323471 Administering azathioprine, 6-mercaptopurine, or 6-thioguanine nucleotide, or their salts for treating graft-versus-host disease of the mouth; oral rinse
01/29/2008US7323467 3-heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics
01/29/2008US7323444 Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis
01/29/2008US7323316 Glycosyltransferase inhibitors
01/29/2008US7323311 Methods of obtaining a specific binding member that binds eotaxin
01/29/2008US7323170 Anti-CD80 antibodies
01/29/2008US7323163 Film-forming compositions and methods
01/29/2008US7323118 Composition of hypochlorous acid and its applications
01/29/2008CA2311128C Composition with azelaic acid
01/29/2008CA2266393C Aqueous antimicrobial liquid cleaning formulation comprising a polymeric deposition aid
01/24/2008WO2008011611A2 Compounds and compositions as itpkb inhibitors
01/24/2008WO2008011364A2 Quercetin-containing compositions
01/24/2008WO2008011363A2 Quercetin-containing compositions
01/24/2008WO2008011313A2 Liquid-containing film structure
01/24/2008WO2008011081A2 Wsx-1/p28 as a target for anti-inflammatory responses
01/24/2008WO2008010403A1 Method for preventing coloration of catechins and dentifrice composition
01/24/2008WO2008009476A2 Concentrated methotrexate solutions
01/24/2008WO2007139948A3 Imidazoazepinone compounds
01/24/2008WO2007139921A3 N-oxides of kappa opioid receptor peptides
01/24/2008WO2007138233A3 Use of zatosetron for the treatment of rosacea, and pharmaceutical compositions
01/24/2008WO2007130075A8 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
01/24/2008WO2007120606A3 Methods for modulating formation and progression of cellulite
01/24/2008US20080021109 5-[3-(2,6-Dimethylbenzyloxy)-phenyl]-pent-4-enoic acid ethyl ester; insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis, arteriosclerosis; side effects reduction; orally active
01/24/2008US20080021106 Cellular uptake of bioactive agents
01/24/2008US20080021094 Treatments for neurogenetic disorders, impulse control disorders, and wound healing
01/24/2008US20080021088 Retinoid Derivatives With Antiangiogenic, Antitumoral And Proapoptotic Activities
01/24/2008US20080021087 Carbamoylamino-substituted 2,3-dihydro-benzofurans, indoles and benzothiophenes, e.g., (+)-N-((3R)-3-(4-isopropylphenyl)-4,6,7-trimethyl-2,3-dihydro-1-benzofuran-5-yl)-3,3-dimethylbutanamide; cerebrovascular disorders
01/24/2008US20080021029 Substituted Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase Inhibitors
01/24/2008US20080021024 Metalloprotease inhibitors
01/24/2008US20080021022 (5-(4-Chlorophenyl)isoxazol-4-yl)(3-(pyridin-3-yl)pyrrolidin-1-yl)methanone; enzyme inhibitor of Hydroxysteroid dehydrogenases; treatment of diabetes, obesity
01/24/2008US20080021017 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
01/24/2008US20080020997 Glucosamine and Glucosamine/Anti-Inflammatory Mutual Prodrugs, Compositions, and Methods
01/24/2008US20080020995 Use of Cyclodextrin Complexes Containing Lipoic Acid
01/24/2008US20080020993 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules
01/24/2008US20080020077 Association Of Vegetal Extracts Based On Gooseberries, Black Orchids And Black Tulips And Topical Composition Comprising The Association Of Said Vegetal Extracts
01/24/2008US20080020075 Topical Cypress Essential Oil Composition for Stretch Marks
01/24/2008US20080020073 Use of oligosaccharides to stimulate beta-endorphin production
01/24/2008US20080020067 Skin Moisturizer
01/24/2008US20080020062 Nutritional composition for the treatment of pressure ulcers
01/24/2008US20080020059 Compositions and methods for topical treatment of skin infection
01/24/2008US20080020025 Composition for wound care and method of using same
01/24/2008US20080020015 Bioactive wound dressings and implantable devices and methods of use
01/24/2008US20080020007 Liquid-containing film structure
01/24/2008US20080019986 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof
01/24/2008US20080019927 Compositions and methods for dermally treating neuropathy with minoxidil
01/24/2008US20080019917 Compositions Comprising Cells and Magnetic Materials for Targeted Delivery
01/24/2008DE10333245B4 Präbiotisch wirksame Pflanzenextrakte Prebiotic active plant extracts
01/24/2008DE102007030198A1 Therapeutic agent, useful for treating skin disease e.g. atopic dermatitis, psoriasis, inflammation, zoster, chickenpox, acne, dandruff head, itching, herpes, shingles, burns, comprises silica sol containing silicon-dioxide
01/24/2008CA2659662A1 Concentrated methotrexate solutions
01/24/2008CA2656715A1 Compounds and compositions as itpkb inhibitors
01/24/2008CA2566562A1 System and process for producing a cleaner containing shell extract and low-suspended solids
01/23/2008EP1881065A1 DINO polypetide
01/23/2008EP1881007A1 LLR-J24 related proteins
01/23/2008EP1880738A1 Medical composition for promotion of skin regeneration
01/23/2008EP1880723A1 Combination of mTOR inhibitor and antifolate compound
01/23/2008EP1880713A1 Use of a preparation of calcium hydroxide and oil for treating skin wounds
01/23/2008EP1880711A1 Parakeratosis inhibitor, pore-shrinking agent and external composition for skin
01/23/2008EP1879595A2 Compositions and methods for treating hyperproliferative epidermal diseases
01/23/2008EP1879449A2 Compositions and methods for skin care
01/23/2008EP1835904A4 Composition for stimulating growth of dermal papilla cells and promoting hair follicle growth comprising vitamin c derivatives
01/23/2008EP1556354B1 Therapeutic piperazine derivates useful for treating pain
01/23/2008EP1545619B1 Solution for ungual application
01/23/2008EP1532144B1 quinuclidine derivatives and their use
01/23/2008EP1501801B1 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
01/23/2008EP1490366B1 alkoxypyridine-derivatives
01/23/2008EP1347768B1 Cosmetic and/or dermopharmaceutical preparations containing leaf extracts of the plant argania spinosa
01/23/2008EP1339687B1 4-6-diphenyl pyridine derivatives as antiinflammatory agents
01/23/2008EP1311261B1 Medicaments for chemotherapeutic treatment of disease
01/23/2008EP1257281B8 Nucleoside analogs with carboxamidine modified monocyclic base
01/23/2008EP1237880B1 Pyrazine based inhibitors of glycogen synthase kinase 3
01/23/2008EP1206937B1 Nitroimidazole external preparations for the treatment of atopic dermatitis